Mirum Pharmaceuticals (MIRM) Gains from Investment Securities (2019 - 2026)
Mirum Pharmaceuticals (MIRM) recorded quarterly Gains from Investment Securities of $4.5 million in Q1 2026, up 213.82% quarter-over-quarter from $1.4 million in Q4 2025, and up 1156.18% on a YoY basis from $356000.0 in Q1 2025.
Mirum Pharmaceuticals (MIRM) Gains from Investment Securities (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Gains from Investment Securities history runs 8 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 1156.18% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $6.6 million (up 548.22% YoY), while the FY2025 annual figure was $2.4 million, up 207.42% from the prior year.
- Gains from Investment Securities was $4.5 million for Q1 2026 at Mirum Pharmaceuticals, up from $1.4 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $8.8 million in Q2 2024 to a low of -$8.1 million in Q3 2024.
- Historically, Gains from Investment Securities has averaged $707848.6 across 5 years, with a median of $200000.0 in 2022.
- Biggest YoY gain for Gains from Investment Securities was 72875.0% in 2024; the steepest drop was 521.95% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at -$300000.0 in 2022, then surged by 141.67% to $125000.0 in 2023, then sank by 80.8% to $24000.0 in 2024, then surged by 5837.5% to $1.4 million in 2025, then jumped by 213.82% to $4.5 million in 2026.
- The last three Gains from Investment Securities figures came in at $4.5 million (Q1 2026), $1.4 million (Q4 2025), and $345000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mirum Pharmaceuticals | 6.29 Bn | 5.90 Bn | 131.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.47 Mn |
| Mar 31, 2026 | 4.47 Mn |
| Dec 31, 2025 | 1.43 Mn |
| Dec 31, 2025 | 1.43 Mn |
| Sep 30, 2025 | 345,000.00 |
| Sep 30, 2025 | 345,000.00 |
| Jun 30, 2025 | 318,000.00 |
| Jun 30, 2025 | 318,000.00 |
| Mar 31, 2025 | 356,000.00 |
| Mar 31, 2025 | 356,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | -8.13 Mn |
| Sep 30, 2024 | -8.13 Mn |
| Jun 30, 2024 | 8.76 Mn |
| Jun 30, 2024 | 8.76 Mn |
| Mar 31, 2024 | 139,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Dec 31, 2023 | 125,000.00 |
| Dec 31, 2023 | 125,000.00 |